Global Digital Pathology Market to Reach $10,193.4 Million by 2035 Driven by AI and ML Integration

Global Digital pathology market was valued at $1,442.0 million in 2025 and is projected to reach $10,193.4 million by 2035, growing at a CAGR of 21.7% during the forecast period (2026-2035). Artificial Intelligence (AI) and Machine Learning (ML) are increasingly integrated into digital pathology workflows, representing a key trend in the global market. These technologies are being embedded within pathology software to automate image analysis, detect anomalies, and classify tissue samples with greater precision. AI/ML tools also support the quantification of biomarkers and tumor characteristics, enabling more accurate and reproducible assessments. By reducing inter-observer variability, these systems contribute to faster and more consistent diagnostic outcomes. In oncology, AI-driven applications are being utilized for early cancer detection and improved disease classification. The adoption of AI and ML reflects a broader shift toward data-driven, computational pathology, enhancing both clinical and research capabilities.

Browse the full report description of “Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software and Storage System), by Application (Teleconsultation, Disease Diagnosis and Drug Discovery and Other) and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals and Others), Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/digital-pathology-market

As the integration of AI continues to shape digital pathology, platforms enabling seamless access to advanced algorithms are becoming increasingly important. These solutions facilitate the adoption of AI tools across diagnostic workflows, supporting tasks such as tissue analysis, biomarker quantification, and cancer risk assessment. By providing flexible, vendor-neutral access, such platforms accelerate the practical implementation of AI-driven pathology on a global scale. For instance, in March 2026, Paige expanded its AppLab marketplace by adding six new digital pathology and AI providers Imagene, Histofy, Aiosyn, Clinsight, DoMore Diagnostics, and Stratipath to enhance diagnostic workflows for cancer. The AppLab allows pathologists to browse, trial, and access AI-powered tools through the Paige Platform and FullFocus viewer, offering vendor-neutral flexibility. The new applications provide capabilities such as biomarker detection, cancer grading, risk stratification, and more, streamlining AI adoption and advancing digital pathology globally.

Key Players Driving Innovation and AI Integration in the Global Digital Pathology Market

The major companies operating in the global digital pathology market include 3DHISTECH Ltd., F. Hoffmann?La Roche Ltd. (Ventana), Hamamatsu Photonics K.K, Leica Biosystems Nussloch GmbH, and Philips (Koninklijke Philips N.V.) among others. These market players are increasingly investing in advanced digital pathology technologies and collaborations to enhance diagnostic accuracy, streamline workflows, and integrate AI-driven tools. Their initiatives focus on improving efficiency, expanding patient access, and establishing scalable platforms that support next-generation computational pathology solutions.

• In September 2025, Labcorp announced a collaboration with Roche to advance its digital pathology capabilities, implementing Roche’s FDA-cleared VENTANA DP 600 and DP 200 slide scanners across its anatomic pathology services. The initiative enables pathologists to diagnose using high-resolution digital images, improves workflow efficiency, and establishes a foundation for future AI integration amid growing diagnostic demand and a projected U.S. pathologist shortage.

• In April 2025, Endeavor Health announced the development of fully cloud-based digital pathology platforms, in collaboration with Google Cloud, to accelerate diagnostic speed, improve accuracy, and expand patient access. By leveraging scalable cloud storage and standards-based systems, the model overcomes traditional barriers of incompatible file formats and isolated systems, enabling a patient-centered, connected approach to diagnostics and advancing the adoption of AI-driven digital pathology across healthcare systems.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
• By Product Type
• By Application
• By End-User
• Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World

• Competitive Landscape - 3DHISTECH Ltd., F. Hoffmann?La Roche Ltd. (Ventana), Hamamatsu Photonics K.K, Leica Biosystems Nussloch GmbH, and Philips (Koninklijke Philips N.V.) among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Digital Pathology Market Report Segment

By Product Type

• Scanner Device
• Software
• Storage System

By Application

• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Other

By End-User

• Biotechnology & Pharmaceutical Companies
• Hospitals
• Others

Global Digital Pathology Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digital-pathology-market